Quidel confident about new urine and vaginal diagnostics
This article was originally published in Clinica
Quidel appears confident of a good market uptake for its new vaginal swab diagnostic and urine analyser devices, which it launched at last week's American Association of Clinical Chemistry meeting, in Orlando, Florida.
You may also be interested in...
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.